Jing-zhou Z. Hou

Jing-zhou Z. Hou

Hematology Oncology

5115 Centre Avenue, Hillman Cancer Center
Pittsburgh, PA 15232

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Structural insight into CD20/CD3-bispecific antibodies by molecular modeling.

Structural insight into CD20/CD3-bispecific antibodies by molecular modeling.

Journal: Computers in biology and medicine

Published: July 30, 2024

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.

Journal: Targeted oncology

Published: August 03, 2023

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.

Journal: Journal of hematology & oncology

Published: March 07, 2021

Pass quantity, focus on quality.

Pass quantity, focus on quality.

Journal: Journal of hematology & oncology

Published: February 09, 2015

Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice.

Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice.

Journal: International journal of cancer

Published: May 15, 2012

Showing 1-5 of 5

Last Updated: 09/26/2026